Rihito Kanamaru
About
In The Last Decade
Rihito Kanamaru
26 papers receiving 449 citations
Peers
Comparison fields: 5 of 60
- Pulmonary and Respiratory Medicine 216
- Oncology 192
- Immunology 119
- Surgery 104
- Gastroenterology 72
Countries citing papers authored by Rihito Kanamaru
This map shows the geographic impact of Rihito Kanamaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rihito Kanamaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rihito Kanamaru more than expected).
Fields of papers citing papers by Rihito Kanamaru
This network shows the impact of papers produced by Rihito Kanamaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rihito Kanamaru. The network helps show where Rihito Kanamaru may publish in the future.
Co-authorship network of co-authors of Rihito Kanamaru
This figure shows the co-authorship network connecting the top 25 collaborators of Rihito Kanamaru. A scholar is included among the top collaborators of Rihito Kanamaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rihito Kanamaru. Rihito Kanamaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 8 | |
| 4 | 26 | |
| 5 | 19 | |
| 6 | 6 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 26 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 63 | |
| 13 | 25 | |
| 14 | 1 | |
| 15 | [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)]. | 68 |
| 16 | [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)]. | 74 |
| 17 | [p53 mutation does not determine prognosis in non-Hodgkin's lymphoma]. | 1 |
| 18 | [Genetic alterations of human colorectal cancer]. | 1 |
| 19 | [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group]. | 8 |
| 20 | [Phase I study of 5'-deoxy-5-fluorouridine (5'-DFUR)]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.